Atlas Trials

Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial

Clinical trial NCT04383717 · UNKNOWN

Trial details

NCT number
NCT04383717
Sponsor
Cairo University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Respiratory Tract Infections
Start date
2020-05-05
Primary completion
2020-08-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.